Immunotherapy has revolutionized the treatment of cancer in recent years and achieved
overall success and long‐term clinical benefit in patients with a wide variety of cancer types …

Immunotherapy is one of the promising strategies in the treatment of oncology. Immune
checkpoint inhibitors, as a type of immunotherapy, have no significant efficacy in the clinical …

Ovarian cancer has the highest mortality rate among gynecologic malignancies. The main
treatment options are surgical removal of the tumor and chemotherapy. Cancer treatment …

As a common malignant tumor of gastrointestinal tract, the incidence of colorectal cancer
(CRC) has gradually increased in recent years. In western developed countries, it has even …

ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) have shown a great therapeutic
efficacy in cancer patients. However, a significant proportion of cancer patients remain …

Background A significant correlation has been identified between lncRNA and tumor cell
resistance, diagnosis, and prognosis. Although mRNA studies have dominated the field of …

Myeloid‐derived suppressor cells (MDSCs) are a heterogenous population of cells that have
been implicated in the development of an immunosuppressive environment, which promotes …

Over the past two decades, immunotherapies have increasingly been considered as first-
line treatments for most cancers. One such treatment is immune checkpoint blockade (ICB) …

T cell transmembrane, Immunoglobulin, and Mucin (TIM) are important immune system
proteins which are especially present in T‐cells and regulated the immune system by …

Immune checkpoints (ICs) are highly expressed on tumor-infiltrating immune cells (TIICs) in
different malignancies, including colorectal cancer (CRC). T cells play crucial roles in …